Different roles for K+ channels in cisplatin-resistant cell lines argue against a critical role for these channels in cisplatin resistance.

Cisplatin resistance has been associated with altered K+ fluxes. Here, we focused our investigations on the detection of K+ channels in a series of cisplatin-resistant (CP-r) cells with increasing resistance and on the functional relationship of these K+ channels to resistance. Microarray analysis and confocal microscopy indicated that there was overexpression of the ether-a-gogo gene (HERG) and the inwardly rectifying potassium channel gene (TWIK) in a human epidermal KB and human liver BEL-7404 carcinoma cell line series selected for cisplatin resistance. With increased resistance, the plasma membrane potential, but not the mitochondrial membrane potential, also increases in these two series. For these reasons, we conducted cell proliferation studies in the presence of either antibodies directed against the detected K+ channels, omeprazole (a H+ pump inhibitor) or a specific inhibitor of the HERG channel (WAY-123398-A-5). The antibodies and omeprazole influenced cell growth only very slightly. The specific K+ channel blocker did not alter cisplatin resistance. We also observed that manipulation of K+ fluxes with antibodies and the H+ pump with omeprazole resulted in opposite effects on cisplatin resistance in these two cell lines. We conclude that K+ and H+ homeostasis are not critical factors in cisplatin resistance since they affect cisplatin resistance differently in KB and BEL-7404 cells.

[1]  H. Hansen,et al.  Magnesium and potassium homeostasis during cisplatin treatment , 2005, Cancer Chemotherapy and Pharmacology.

[2]  John N Weinstein,et al.  Analysis of ATP-Binding Cassette Transporter Expression in Drug-Selected Cell Lines by a Microarray Dedicated to Multidrug Resistances⃞ , 2004, Molecular Pharmacology.

[3]  Jie Huang,et al.  Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells. , 2004, Molecular cancer therapeutics.

[4]  L. Kèlland,et al.  Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and-resistant human ovarian carcinoma cell lines by amphotericin B , 2004, Cancer Chemotherapy and Pharmacology.

[5]  Z. Siddik,et al.  Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.

[6]  M. Gottesman,et al.  Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines. , 2003, Cancer research.

[7]  C. Cullinane,et al.  Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines. , 2003, Molecular pharmacology.

[8]  D. A. Brown,et al.  Dominant-Negative Subunits Reveal Potassium Channel Families That Contribute to M-Like Potassium Currents , 2002, The Journal of Neuroscience.

[9]  Toshitaka Nakamura,et al.  Elevated expression of vacuolar proton pump genes and cellular ph in cisplatin resistance , 2001, International journal of cancer.

[10]  K. Maheswari,et al.  Interaction of cisplatin with planar model membranes - dose dependent change in electrical characteristics. , 2000, Biochimica et biophysica acta.

[11]  K. Paull,et al.  Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. , 1996, Biochemical pharmacology.

[12]  J. Glockner,et al.  CHAPTER 21 – MEASUREMENTS OF THE CONCENTRATION OF OXYGEN IN BIOLOGICAL SYSTEMS USING EPR TECHNIQUES , 1989 .

[13]  J. Bolard,et al.  Recovery of hepatocytes from attack by the pore former amphotericin B. , 1988, The Biochemical journal.

[14]  D. Schlessinger,et al.  Stimulatory, permeabilizing, and toxic effects of amphotericin B on L cells , 1984, Antimicrobial Agents and Chemotherapy.